Q2 2025 Holdings
Filed 2025-08-14 | 158 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $149 | 248,506 | 0.0% |
| Perfect Corp | *W EXP 99/99/999 | G7006A117 | $660 | 16,075 | 0.0% |
| Biodesix Inc | COM | 09075X108 | $24.0K | 84,903 | 0.0% |
| Guardforce AI Co LTD | *W EXP 10/01/202 | G4236L120 | $37.7K | 154,205 | 0.0% |
| Transact Technologies Inc(TACT) | COM | 892918103 | $55.1K | 15,046 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $91.8K | 6,703 | 0.0% |
| Lucid Diagnostics Inc(LUCD) | COM | 54948X109 | $108.7K | 94,541 | 0.0% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $129.6K | 54,208 | 0.0% |
| Childrens PL Inc New(PLCE) | COM | 168905107 | $252.6K | 57,030 | 0.0% |
| Ladder Cap Corp(LADR) | CL A | 505743104 | $273.1K | 25,401 | 0.0% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $347.7K | 205,760 | 0.0% |
| Evoke Pharma Inc(EVOK) | COM | 30049G302 | $385.2K | 148,153 | 0.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $427.1K | 61,186 | 0.0% |
| Fortress Biotech Inc(FBIO) | COM NEW | 34960Q307 | $605.5K | 325,520 | 0.0% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $608.0K | 211,110 | 0.0% |
| Spar Group Inc(SGRP) | COM | 784933103 | $634.3K | 660,688 | 0.0% |
| Pathward Financial Inc(CASH) | COM | 59100U108 | $659.9K | 8,341 | 0.0% |
| Acme UTD Corp(ACU) | COM | 004816104 | $846.7K | 20,427 | 0.0% |
| Olaplex Hldgs Inc(OLPX) | COM | 679369108 | $910.0K | 650,000 | 0.0% |
| Talphera Inc(TLPH) | COM NEW | 00444T209 | $917.0K | 1,992,519 | 0.0% |
| Evolus Inc(EOLS)Call | COM | 30052C107 | $921.0K | 100,000 | 0.0% |
| Strata Skin Sciences Inc(SSKN) | COM | 86272A305 | $925.0K | 403,917 | 0.0% |
| Biomx Inc | COM NEW | 09090D301 | $1.1M | 2,493,309 | 0.0% |
| Dariohealth Corp(DRIOEUR) | COM NEW | 23725P209 | $1.1M | 1,692,303 | 0.0% |
| Altisource Portfolio Solutio | REG SHS | L0175J104 | $1.2M | 135,601 | 0.0% |
| Altisource Portfolio Solutio | *W EXP 04/02/202 | L0175J120 | $1.2M | 2,477,312 | 0.0% |
| Altisource Portfolio Solutio | *W EXP 04/30/203 | L0175J112 | $1.3M | 2,477,312 | 0.0% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.3M | 1,935,484 | 0.0% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $1.3M | 625,000 | 0.0% |
| Perfect Corp | CL A ORD SHS | G7006A109 | $1.3M | 583,925 | 0.1% |
| Tela BIO Inc(TELA)Call | COM | 872381108 | $1.5M | 750,000 | 0.1% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $1.6M | 351,878 | 0.1% |
| Senti Biosciences Inc(SNTI) | COM NEW | 81726A209 | $1.9M | 888,000 | 0.1% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $2.0M | 898,885 | 0.1% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.1M | 229,527 | 0.1% |
| Scully Royalty LTD(SRL) | COM SHS | G7T96K107 | $2.1M | 368,182 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $2.2M | 590,884 | 0.1% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $2.4M | 1,086,812 | 0.1% |
| Envveno Medical Corporation | COM | 29415J106 | $2.4M | 594,661 | 0.1% |
| Reading Intl Inc(RDI) | CL A | 755408101 | $2.6M | 1,921,088 | 0.1% |
| Caesars Entertainment Inc NE(CZR) | COM | 12769G100 | $2.8M | 98,879 | 0.1% |
| Destination XL Group Inc(DXLG) | COM | 25065K104 | $2.9M | 2,576,774 | 0.1% |
| Kosmos Energy LTD(KOS) | COM | 500688106 | $3.0M | 1,716,593 | 0.1% |
| Abeona Therapeutics Inc(ABEO)Call | COM NEW | 00289Y206 | $3.0M | 520,000 | 0.1% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $3.1M | 1,141,237 | 0.1% |
| Columbus Mckinnon Corp N Y(CMCO) | COM | 199333105 | $3.1M | 203,628 | 0.1% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $3.1M | 150,000 | 0.1% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $3.2M | 3,345,923 | 0.1% |
| Noodles & Co(NDLSUSD) | COM CL A | 65540B105 | $3.2M | 4,505,489 | 0.1% |
| Neuropace Inc(NPCE) | COM | 641288105 | $3.3M | 295,089 | 0.1% |